Literature DB >> 234268

Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration.

J B Ferriss, J J Brown, R Fraser, E Haywood, D L Davies, A W Kay, A F Lever, J I Robertson, K Owen, W S Peart.   

Abstract

Fifty patients with hypertension, aldosterone excess, and low plasma renin concentration underwent adrenal surgery. There was a highly significant fall in mean systolic and diastolic pressures after the operation. The mean postoperative diastolic pressure fell to strictly normal levels, however, in only 19 out of 38 patients from whom an adrenocortical adenoma was removed and in only two out of 10 non-tumour patients. There was a significant correlation between the fall in blood pressure during spironolactone treatment and after adrenal surgery though levels were generally slightly lower during the former therapy. It is suggested that removal of an aldosterone-producing adenoma is the treatment of choice provided a good preoperative hypotensive response to spironolactone occurs, while the treatment of choice for non-tumour patients is often long-term spironolactone.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 234268      PMCID: PMC1671982          DOI: 10.1136/bmj.1.5950.135

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  17 in total

Review 1.  CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

Authors:  J W CONN; R F KNOPF; R M NESBIT
Journal:  Am J Surg       Date:  1964-01       Impact factor: 2.565

2.  Simultaneous measurement of total exchangeable potassium and sodium using 43 K and 24 Na.

Authors:  D L Davies; J W Robertson
Journal:  Metabolism       Date:  1973-02       Impact factor: 8.694

3.  Primary aldosteronism: experience with current diagnostic criteria and surgical treatment in fourteen patients.

Authors:  R K Rhamy; R M McCoy; H W Scott; L M Fishman; A M Michelakis; G W Liddle
Journal:  Ann Surg       Date:  1968-05       Impact factor: 12.969

4.  Aldosteronism in hypertension. The spironolactone response test.

Authors:  R F Spark; J C Melby
Journal:  Ann Intern Med       Date:  1968-10       Impact factor: 25.391

5.  Falsely high plasma potassium values in patients with hyperaldosteronism.

Authors:  J J Brown; R H Chinn; D L Davies; R Fraser; A F Lever; R J Rae; J I Robertson
Journal:  Br Med J       Date:  1970-04-04

6.  Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour.

Authors:  J B Ferriss; J J Brown; R Fraser; A W Kay; A M Neville; I G O'Muircheartaigh; J I Robertson; T Symington; A F Lever
Journal:  Lancet       Date:  1970-11-14       Impact factor: 79.321

7.  Primary aldosteronism with suppressed plasma renin activity due to bilateral nodular adrenocortical hyperplasia.

Authors:  F H Katz
Journal:  Ann Intern Med       Date:  1967-11       Impact factor: 25.391

8.  Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein cateterization.

Authors:  J C Melby; R F Spark; S L Dale; R H Egdahl; P C Kahn
Journal:  N Engl J Med       Date:  1967-11-16       Impact factor: 91.245

9.  Pathology of primary aldosteronism.

Authors:  A M Neville; T Symington
Journal:  Cancer       Date:  1966-12       Impact factor: 6.860

View more
  11 in total

1.  Primary aldosteronism: how hard should we look?

Authors:  J D Swales
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-10

2.  Primary aldosteronism.

Authors: 
Journal:  Br Med J       Date:  1980-03-08

3.  Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.

Authors:  David C Kem; Hongliang Li; Carolina Velarde-Miranda; Campbell Liles; Megan Vanderlinde-Wood; Allison Galloway; Muneer Khan; Caitlin Zillner; Alexandria Benbrook; Veitla Rao; Celso E Gomez-Sanchez; Madeleine W Cunningham; Xichun Yu
Journal:  J Clin Endocrinol Metab       Date:  2014-02-19       Impact factor: 5.958

4.  Primary aldosteronism due to adrenal carcinomas.

Authors:  T Lüscher; W Tenschert; A Salvetti; R Pedrinelli; R Maurer; F Turini; G Maltinti; H Vetter; W Vetter
Journal:  Klin Wochenschr       Date:  1984-05-15

5.  Surgical treatment of primary hyperaldosteronism.

Authors:  R J Weigel; S A Wells; J C Gunnells; G S Leight
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

6.  Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands.

Authors:  T Jeck; B Weisser; T Mengden; L Erdmenger; S Grüne; W Vetter
Journal:  Clin Investig       Date:  1994-12

7.  Initiation of hypertension in utero and its amplification throughout life.

Authors:  C M Law; M de Swiet; C Osmond; P M Fayers; D J Barker; A M Cruddas; C H Fall
Journal:  BMJ       Date:  1993-01-02

8.  Therapeutic results of primary aldosteronism with special reference to renal or renovascular lesions.

Authors:  T Nakada; H Koike; T Akiya; T Katayama; M Takata; H Iida; Y Mizumura
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

9.  Evolution of the surgical management of primary aldosteronism.

Authors:  S P Auda; M F Brennan; J R Gill
Journal:  Ann Surg       Date:  1980-01       Impact factor: 12.969

10.  Primary aldosteronism by carcinoma of the adrenal cortex.

Authors:  W Tenschert; R Maurer; H Vetter; W Vetter
Journal:  Klin Wochenschr       Date:  1987-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.